National COVID-19 Convalescent Plasma Project National COVID-19 Convalescent Plasma Project

National COVID-19 Convalescent Plasma Project

National COVID-19 Convalescent Plasma Project

  • Who are we?
  • Evidence
  • Virology
  • Key Scientific Papers
  • Home

Site Map

  • Who are we?
    • Who are we?
    • Participating Institutions
    • Investigators
    • Basic Principles
  • Evidence
    • Weighing the Evidence
    • Randomized Trials
      • Randomized Trials
    • News
      • 2020 News
        • IDSA Supports FDA Action on Emergency Investigational Convalescent Plasma Treatment for COVID-19
        • Statement From the Presidents of the NAS, NAE, and NAM Supporting Steps Necessary to Assess the Potential for Human Convalescent Plasma to Help Control COVID-19
        • FDA Licenses First COVID-19 Anti-body Test
        • 2020 News
      • 2021 News
      • 2022 News
      • 2023 News
      • New York Blood Center to Collect First Blood Plasma Donations from Recovered COVID-19 Patients to Treat Severe Cases
      • News
    • Regulatory Issues
      • Regulatory Issues
  • Virology
    • Virology
    • Antibody Detection
    • Virus Detection
    • Serology Tests
    • Molecular Tests
    • Pregnancy and Antibodies
    • Vaccine and Antibodies
  • Key Scientific Papers
    • Our Key Scientific Papers
    • Other Key Scientific Papers
  • Home
  • Contact Us
  • Privacy Statement
  • Site Accessibility
  • Site Map
  • Search
  • Give
  • Facebook
  • Twitter
  • Contact Information
  • Site Map
  • Privacy Statement
  • Give
Michigan State University wordmark